Top compounds associated with response to LYRM5


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin gCSI pan-cancer AAC -0.005 0.9
mRNA MS-275 gCSI pan-cancer AAC -0.027 0.6
mRNA Crizotinib gCSI pan-cancer AAC 0.029 0.6
mRNA PD-0325901 gCSI pan-cancer AAC -0.028 0.6
mRNA Vorinostat gCSI pan-cancer AAC -0.034 0.5
mRNA Docetaxel gCSI pan-cancer AAC -0.055 0.3
mRNA paclitaxel gCSI pan-cancer AAC -0.055 0.3
mRNA bid1870 gCSI pan-cancer AAC -0.062 0.2
mRNA GDC-0941 gCSI pan-cancer AAC -0.069 0.2
mRNA Irinotecan gCSI pan-cancer AAC -0.083 0.1
Download CSV